How much funding has Camp4 raised?

Camp4 has raised $100.0M in total funding, most recently a Series B round.

Who are Camp4's investors?

Camp4's investors include Patient Square Capital, Andreessen Horowitz.

Where is Camp4 headquartered?

Camp4 is headquartered in Cambridge, Massachusetts, United States.

Camp4

CAMP4 Therapeutics - Pioneering a new class of RNA medicines to increase targeted gene expression

Cambridge, United States · Founded 2016 · $100.0M raised

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: camp4tx.com
Total Funding: $100.0M
Last Round: $100.0M Series BJul 2022
Rounds: 1

About

CAMP4 Therapeutics is a clinical-stage biotech pioneering programmable RNA therapeutics for haploinsufficient diseases. Its regRNA platform combines gene regulation insights with computational biology to increase gene dosage in conditions where one functional gene copy is insufficient, targeting rare neurological and other genetic disorders.

Summary

Camp4 is a Healthcare company based in Cambridge, United States, founded in 2016. It has raised $100.0M in total across 1 round, most recently a $100.0M Series B round in Jul 2022. Investors include Patient Square Capital and Andreessen Horowitz.

LinkedIn X (Twitter)